© Brighteon.com All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. Brighteon is not responsible for comments and content uploaded by our users.
Redacted, July 21, 2023
The FDA approved a shot for Respiratory Syncytial Virus or RSV for babies born during RSV season and children up to 24 months old who remain vulnerable to RSV. It is not a vaccine but rather an injection of antibodies. The shot is called Beyfortus and it is made by AstraZeneca and Sanofi. It was given FastTrack designation for this approval, meaning it was expedited and accelerated. But is it safe? The media is not covering the clinical trials so we will. It is by no means a slam dunk.
Redacted
https://redacted.inc